Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
5131 participants
OBSERVATIONAL
2022-07-04
2023-06-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects on the Scalp Lipids and TEWL of a 1% Selenium Disulfide and 1% Salicylic Acid Antidandruff Shampoo on Dandruff Scalp
NCT05503706
Evaluation of the Efficacy of SeS2 Shampoo on Subjects Having Dandruff
NCT05506592
Evaluation and Comparison of the Benefits of Routine vs Shampoo Alone During 4 Weeks Treatment and 12 Weeks Remanence
NCT07133334
Evaluation of the Benefits of Shampoo During 4 Weeks of Treatment and After 24 Weeks
NCT07292467
Demonstration of Carbonyl Stress on Hair Follicles
NCT03414476
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dermocosmetic product: Selenium Disluphide Shampoo (Dercos DS)
to assess the benefit of Dercos DS in subjects with dandruff
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All hair types
* All ethnicities (Asian, Caucasian, Afro-American, African, Hispanic)
* Including patients with specific occlusion habits (for instance veil use at least 8 hours per day, hat use)
* Patients willing to provide written informed consent
Exclusion Criteria
* Pregnancy, breast feeding, childbearing potential without adequate contraception, or irregular menstrual cycles.
* History of allergy, anaphylaxis or hypersensitivity to any of the ingredients of Shampoo any of the ingredients of DERCOS ANTI-DANDRUFF normal to oily hair shampoo
* History of allergic contact dermatitis secondary to shampoo, conditioner, mask, and/or leave-in.
* Has any clinical manifestations in the treatment(s) or other disorders that, in the opinion of the investigator, may affect the evaluations or results of the study products.- Inability to stay the study period (56 days +-5 days) without performing any hair/scalp procedure, including coloring, straightening and cutting.
* Inability to attend all study visits and follow treatment regimen
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cosmetique Active International
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Marta Sar Pormian
Warsaw, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Dercos DS in Dandruff
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.